Skip to Main Content

Author Details

Jonathan Kimmelman
McGill University
1977
180
33
PMIDPaper TitleJournal TitlePublished Year
37873661The impact of feedback training on prediction of cancer clinical trial results.Clin Trials2024
37028684Bypassing phase 2 in cancer drug development erodes the risk/benefit balance in phase 3 trials.J Clin Epidemiol2023
37752147Large numbers of patients are needed to obtain additional approvals for new cancer drugs: A retrospective cohort study.Sci Rep2023
37657661Timing for First-in-Minor Clinical Trials of New Cancer Drugs.J Pediatr2023
37211326Matured forecast analyses for "systematic and narrative review lead experts to different cancer trial predictions".J Clin Epidemiol2023
35134071Principal investigators over-optimistically forecast scientific and operational outcomes for clinical trials.PLoS One2022
35739610Success rates for US and Canadian anticancer drug development efforts in pediatric oncology.Pediatr Blood Cancer2022
35584654Completeness of clinical evidence citation in trial protocols: A cross-sectional analysis.Med2022
35348360Practical steps to identifying the research risk of pragmatic trials.Clin Trials2022
35764764Quantifying Patient Investment in Novel Neurological Drug Development.Neurotherapeutics2022
35361655Interventions for physician prescribers of opioids for chronic non-cancer pain: protocol for an overview of systematic reviews.BMJ Open2022
36410007Participant Recruitment From Low- and Middle-Income Countries for Pivotal Trials of Drugs Approved by the U.S. Food and Drug Administration : A Cross-Sectional Analysis.Ann Intern Med2022
36510308Competition for recruitment in SARS-CoV-2 Trials in the United States: a longitudinal cohort analysis.BMC Res Notes2022
36484509Clarifying the Ethics and Oversight of Chimeric Research.Hastings Cent Rep2022
36094914Diminishing clinical impact for post-approval cancer clinical trials: A retrospective cohort study.PLoS One2022
35975784The proportion of randomized controlled trials that inform clinical practice.Elife2022
35275736Ethical Considerations for Phase I Trials in Oncology.J Clin Oncol2022
35061758How informative were early SARS-CoV-2 treatment and prevention trials? a longitudinal cohort analysis of trials registered on ClinicalTrials.gov.PLoS One2022
32681475The proportion of North American cancer trials that evaluate novel targets.Invest New Drugs2021
34874006Is preclinical research in cancer biology reproducible enough?Elife2021
34738471<i>Clinical Trials</i> to authors: Please pre-register your studies!Clin Trials2021
34642487Individualized therapy trials: navigating patient care, research goals and ethics.Nat Med2021
34464184The Effect of Overdose Education and Naloxone Distribution: An Umbrella Review of Systematic Reviews.Am J Public Health2021
34214412The Effect of Overdose Education and Naloxone Distribution: An Umbrella Review of Systematic Reviews.Am J Public Health2021
34003270Patient Participation in Clinical Trials of Oncology Drugs and Biologics Preceding Approval by the US Food and Drug Administration.JAMA Netw Open2021
34048692ISSCR Guidelines for Stem Cell Research and Clinical Translation: The 2021 update.Stem Cell Reports2021
33346013Systematic review and narrative review lead experts to different cancer trial predictions: a randomized trial.J Clin Epidemiol2021
33226855Probability of Success and Timelines for the Development of Vaccines for Emerging and Reemerged Viral Infectious Diseases.Ann Intern Med2021
33231112Commentary on Kahrass et al: The sublime inertia of informed consent language in early phase clinical trials involving patients.Clin Trials2021
33002259Comparison of Patient and Expert Perceptions of the Attainment of Research Milestones in Parkinson's Disease.Mov Disord2021
32936509Can Oncologists Predict the Efficacy of Treatments in Randomized Trials?Oncologist2021
31580145Benefit, burden, and impact for a cohort of post-approval cancer combination trials.Clin Trials2020
31910134What Research Ethics (Often) Gets Wrong about Minimal Risk.Am J Bioeth2020
31877086Ethical and Policy Issues for Seamless Phase I Oncology Trials.J Clin Oncol2020
31866472Group sample sizes in nonregulated health care intervention trials described as randomized controlled trials were overly similar.J Clin Epidemiol2020
31722417Impact of Precision Medicine on Efficiencies of Novel Drug Development in Cancer.J Natl Cancer Inst2020
32071183Patient burden and clinical advances associated with postapproval monotherapy cancer drug trials: a retrospective cohort study.BMJ Open2020
31857690Reply to 'Correcting the ASCO position on phase I clinical trials in cancer'.Nat Rev Clin Oncol2020
31977931A systematic review and meta-analysis of pregabalin preclinical studies.Pain2020
31649355Imatinib and the long tail of targeted drug development.Nat Rev Clin Oncol2020
31792092Risks and benefits of unapproved disease-modifying treatments for neurodegenerative disease.Neurology2020
33416651What Is Human Research For? Reflections on the Omission of Scientific Integrity from the <i>Belmont Report</i>.Perspect Biol Med2020
33416648Introduction to the Special Issue on the <i>Belmont Report</i>.Perspect Biol Med2020
32579564Clinical development success rates and social value of pediatric Phase 1 trials in oncology.PLoS One2020
32975817Why IRBs should protect bystanders in human research.Bioethics2020
32989715Expert Forecasts of COVID-19 Vaccine Development Timelines.J Gen Intern Med2020
32646992Unnecessary hesitancy on human vaccine tests-Response.Science2020
32956259Response to Moisset et al.Pain2020
32588447Decision analysis approach to risk/benefit evaluation in the ethical review of controlled human infection studies.Bioethics2020
32333550Forecasts for the Attainment of Major Research Milestones in Parkinson's Disease.J Parkinsons Dis2020
  • 1 - 50 of 180

Recommended Authors

Nicole M Zaleski
Career Start Year 2017
Number of shared co-authors 0
Kayte Spector-Bagdady
University of Michigan Medical School.
Career Start Year 2013
Number of shared co-authors 3
Nicholas S Downing
Center for Outcomes Research and Evaluation, Yale-New Haven Hospital
Career Start Year 2012
Number of shared co-authors 1
David Shaw
Care and Public Health Research Institute, Maastricht University
Career Start Year 2011
Number of shared co-authors 0
Danielle Whicher
Tennessee Valley Healthcare System
Career Start Year 2009
Number of shared co-authors 0
Jennifer B McCormick
Penn State College of Medicine
Career Start Year 2006
Number of shared co-authors 15
Jill M Pulley
Vanderbilt University School of Medicine
Career Start Year 2005
Number of shared co-authors 2
June M McKoy
Feinberg School of Medicine, Northwestern University
Career Start Year 2003
Number of shared co-authors 0
Rebecca N Jerome
12328Vanderbilt University Medical Center
Career Start Year 2001
Number of shared co-authors 0
An-Wen Chan
8 Women's College Research Institute, University of Toronto
Career Start Year 2000
Number of shared co-authors 2
Ivan Glenn Cohen
Petrie-Flom Center for Health Law Policy, Harvard University
Career Start Year 2000
Number of shared co-authors 15
Ana S Iltis
Department of Philosophy and Center for Bioethics, Wake Forest University
Career Start Year 2000
Number of shared co-authors 5
Steven Joffe
Medical Ethics and Health Policy, University of Pennsylvania
Career Start Year 1999
Number of shared co-authors 11
Deborah Collyar
Clinical Trials Information Project
Career Start Year 1999
Number of shared co-authors 3
Joseph S Ross
Yale School of Medicine
Career Start Year 1999
Number of shared co-authors 4
Scott M Berry
University of Kansas Medical Center
Career Start Year 1998
Number of shared co-authors 0
David Magnus
Stanford Center for Biomedical Ethics, Stanford University
Career Start Year 1998
Number of shared co-authors 8
Carolyn Riley Chapman
Center for Human Genetics and Genomics, NYU Grossman School of Medicine
Career Start Year 1997
Number of shared co-authors 5
Nikolajs Zeps
Queensland University of Technology
Career Start Year 1996
Number of shared co-authors 4
David Wendler
NIH Clinical Center
Career Start Year 1996
Number of shared co-authors 1
Lois Shepherd
Queens University
Career Start Year 1991
Number of shared co-authors 2
Benjamin S Wilfond
University of Washington School of Medicine.
Career Start Year 1990
Number of shared co-authors 12
Sean Tunis
Center for Evaluation of Value and Risk in Health, Tufts Medical Center
Career Start Year 1987
Number of shared co-authors 0
Mildred K Cho
Center for Biomedical Ethics, Stanford University School of Medicine
Career Start Year 1985
Number of shared co-authors 14
Benjamin Djulbegovic
Medical University of South Carolina
Career Start Year 1985
Number of shared co-authors 1
Susan M Wolf
Law School and Medical School, University of Minnesota
Career Start Year 1984
Number of shared co-authors 7
Christine Grady
National Institutes of Health Clinical Center
Career Start Year 1984
Number of shared co-authors 5
Donald A Berry
MD Anderson Cancer Center
Career Start Year 1980
Number of shared co-authors 2
Arthur L Caplan
Division of Medical Ethics, New York University Grossman School of Medicine
Career Start Year 1976
Number of shared co-authors 16
David L DeMets
University of Wisconsin
Career Start Year 1971
Number of shared co-authors 1

Collaborators

Alex John London
Department of Philosophy and Center for Ethics and Policy, Carnegie Mellon University
Co-authored papers 14
Holly Fernandez Lynch
University of Pennsylvania Perelman School of Medicine.
Co-authored papers 6
Douglas Sipp
RIKEN Center for Biosystems Dynamics Research
Co-authored papers 6
Timothy Caulfield
Faculty of Law and School of Public Health, University of Alberta
Co-authored papers 6
Jeremy Sugarman
Johns Hopkins University, Berman Institute of Bioethics
Co-authored papers 6
Insoo Hyun
Center for Bioethics, Harvard Medical School
Co-authored papers 6
George Q Daley
Boston Children's Hospital, Harvard Medical School
Co-authored papers 5
Roger A Barker
John Van Geest Center for Brain Repair, University of Cambridge
Co-authored papers 4
Jeffrey Peppercorn
Massachusetts General Hospital, Harvard Medical School
Co-authored papers 3
Lorenz Studer
The Center for Stem Cell Biology, Memorial Sloan Kettering Cancer Center
Co-authored papers 3
James A Anderson
The Hospital for Sick Children
Co-authored papers 3
Patricia J Zettler
Moritz College of Law and Comprehensive Cancer Center, The Ohio State University
Co-authored papers 2
Mithat Gonen
Co-authored papers 2
Megan Munsie
Stem Cell Ethics & Policy Group
Co-authored papers 2
Heather M Rooke
Broad Institute of Harvard and MIT
Co-authored papers 2
Ubaka Ogbogu
University of Alberta
Co-authored papers 2
Rebecca C Auer
The Ottawa Hospital Research Institute
Co-authored papers 2
Nancy S Jecker
University of Washington School of Medicine
Co-authored papers 2
Judy Illes
University of British Columbia.
Co-authored papers 2
Kazuto Kato
Osaka University
Co-authored papers 2
Leigh Turner
University of California irvine
Co-authored papers 2
E Clayton
Harvard Medical School, Vanderbilt University, Yale University Yale Law School
Co-authored papers 1
Jeffrey P Kahn
Berman Institute of Bioethics, Johns Hopkins University
Co-authored papers 1
Yali Cong
Department of Medical Ethics and Law, Peking University Health Science Center
Co-authored papers 1
Amander T Clark
Center for Reproductive Science, University of California los angeles
Co-authored papers 1
Hiromitsu Nakauchi
Advanced Research Institute, Tokyo Medical and Dental University
Co-authored papers 1
Amy Zarzeczny
University of Regina
Co-authored papers 1
Friedemann Paul
Max-Delbruck Center for Molecular Medicine in the Helmholtz Association
Co-authored papers 1
Nuria Montserrat
Catalan Institution for Research and Advanced Studies (ICREA)
Co-authored papers 1
Mitinori Saitou
Institute for the Advanced Study of Human Biology (ASHBi), Kyoto University
Co-authored papers 1
Release 1.2